Rhelion Subsidiary to Supply Belgium’s First Psilocybin Compassionate Use Program
Rhelion Life Sciences says its wholly owned subsidiary Filament Health will supply Belgium’s first psilocybin compassionate use program.
Story updates
12:57:05 PM UTC
SquawkNews
Rhelion said subsidiary Filament Health signed a supply and licensing deal to provide PEX010 to a Belgian compassionate use program for treatment-resistant depression, pending regulatory approval.Material DetailsContext by AI AnalystThis extends Rhelion/Filament’s push to supply regulated psilocybi…